title: Prevention of post-partum hemorrhage by rectal Misoprostol: A randomized clinical trial.
abstract: BACKGROUND
  Post-partum hemorrhage (PPH) is a common cause of maternal mortality in developing countries. This trial was conducted to study the effectiveness and safety of rectal misoprostol for PPH.
  
  
  OBJECTIVE
  To assess the effectiveness and safety of misoprostol and comparing with oxytocin for prevention of PPH.
  
  
  METHODS
  Women were randomized to receive either two 200 μg rectal misoprostol tablets (study group) or 20 units oxytocin in 1000 cc normal saline intravenously (control group). The outcomes were incidence of PPH, amount of blood loss, duration of labor, incidence of side effects, pre- and post-delivery hemoglobin, and use of additional uterotonics.
  
  
  RESULTS
  The incidence of PPH was 12% in the study group and 10% in the control group (P > 0.05). No significant difference was observed between the groups hematocrit (P > 0.05). Other variables including severe PPH and duration of the third stage of labor were similar in both groups.
  
  
  CONCLUSIONS
  Rectal misoprostol was as effective as intravenous oxytocin for preventing post-partum hemorrhage with the same incidence of side effects and is recommended to be use as an uterotonic agent to manage third stage of labor routinely.
authors: Department of Nursing and Midwifery, Islamic Azad University, Babol, Iran.
authors: Mozhgan
authors: M
authors: Firouzbakht
authors: Azadeh
authors: A
authors: Kiapour
authors: Shabnam
authors: S
authors: Omidvar
keywords: Active management; misoprostol; oxytocin; post-partum hemorrhage; third stage
references: BJOG. 2011 Feb;118(3):353-61
references: 21176086
references: Afr J Reprod Health. 2009 Jun;13(2):87-95
references: 20690252
references: J Obstet Gynaecol Can. 2002 Feb;24(2):149-54
references: 12196880
references: Int J Gynaecol Obstet. 2009 Jun;105(3):244-7
references: 19249048
references: Bull World Health Organ. 2009 Sep;87(9):666-77
references: 19784446
references: Int J Gynaecol Obstet. 2006 Jan;92(1):10-8
references: 16309682
references: Obstet Gynecol. 2003 May;101(5 Pt 1):968-74
references: 12738159
references: Int J Gynaecol Obstet. 2001 Apr;73(1):1-6
references: 11336714
references: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000494
references: 17636640
references: Arch Gynecol Obstet. 2011 May;283(5):935-9
references: 20422423
references: BJOG. 2000 Sep;107(9):1111-5
references: 11002954
references: Int J Gynaecol Obstet. 2010 Mar;108(3):276-81
references: 20053399
references: BJOG. 2011 Mar;118(4):466-73
references: 21199290